[Comparative pharmacoeconomic evaluation of various approaches to antibacterial therapy of ventilator-associated pneumonia].
Rudnov
V A
VA
Ural State Medical Academy, Ekaterinburg.
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D002442:Ceftazidime / Q000191:economics / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000191:economics* / Q000209:etiology; D004359:Drug Therapy, Combination / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D000077731:Meropenem; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000191:economics* / Q000209:etiology; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000295:instrumentation; D013845:Thienamycins / Q000191:economics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D002442:Ceftazidime; D000077731:Meropenem